Herzig GP - Search Results

1

Cerebellar toxicity with high-dose cytosine arabinoside.

Herzig RH, Hines JD, Herzig GP, Wolff SN, Cassileth PA, Lazarus HM, Adelstein DJ, Brown RA, Coccia PF, Strandjord S, et al. Herzig RH, et al. Among authors: herzig gp. J Clin Oncol. 1987 Jun;5(6):927-32. doi: 10.1200/JCO.1987.5.6.927. J Clin Oncol. 1987. PMID: 3585447

2

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.

Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP. Wolff SN, et al. Among authors: herzig rh, herzig gp. J Clin Oncol. 1989 Sep;7(9):1260-7. doi: 10.1200/JCO.1989.7.9.1260. J Clin Oncol. 1989. PMID: 2769327

3

High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.

Wolff SN, Herzig RH, Phillips GL, Lazarus HM, Greer JP, Stein RS, Ray WA, Herzig GP. Wolff SN, et al. Among authors: herzig rh, herzig gp. Semin Oncol. 1987 Jun;14(2 Suppl 1):12-7. Semin Oncol. 1987. PMID: 3589687

4

Central nervous system effects of high-dose cytosine arabinoside.

Herzig RH, Herzig GP, Wolff SN, Hines JD, Fay JW, Phillips GL. Herzig RH, et al. Among authors: herzig gp. Semin Oncol. 1987 Jun;14(2 Suppl 1):21-4. Semin Oncol. 1987. PMID: 3589694 No abstract available.

5

Central nervous system toxicity with high-dose cytosine arabinoside.

Herzig RH, Lazarus HM, Herzig GP, Coccia PF, Wolff SN. Herzig RH, et al. Among authors: herzig gp. Semin Oncol. 1985 Jun;12(2 Suppl 3):233-6. Semin Oncol. 1985. PMID: 3892703 No abstract available.

6

High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.

Herzig RH, Lazarus HM, Wolff SN, Phillips GL, Herzig GP. Herzig RH, et al. Among authors: herzig gp. J Clin Oncol. 1985 Jul;3(7):992-7. doi: 10.1200/JCO.1985.3.7.992. J Clin Oncol. 1985. PMID: 3894588 Clinical Trial.

7

High-dose cytosine arabinoside therapy for refractory leukemia.

Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C, Herzig GP. Herzig RH, et al. Among authors: herzig gp. Blood. 1983 Aug;62(2):361-9. Blood. 1983. PMID: 6223674 Free article.

8

Bone marrow transplantation with high-dose cytosine arabinoside.

Herzig RH, Lazarus HM, Graham-Pole J, Gross S, Coccia P, Gordon EM, Strandjord S, Phillips GL, Herzig GP. Herzig RH, et al. Among authors: herzig gp. Med Pediatr Oncol. 1982;10 Suppl 1:235-8. doi: 10.1002/mpo.2950100724. Med Pediatr Oncol. 1982. PMID: 6761567

9

Central nervous system toxicity of high-dose systemic cytosine arabinoside.

Lazarus HM, Herzig RH, Herzig GP, Phillips GL, Roessmann U, Fishman DJ. Lazarus HM, et al. Among authors: herzig rh, herzig gp. Cancer. 1981 Dec 15;48(12):2577-82. doi: 10.1002/1097-0142(19811215)48:12<2577::aid-cncr2820481207>3.0.co;2-z. Cancer. 1981. PMID: 7306918

10

High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.

Lazarus HM, Phillips GL, Herzig RH, Hurd DD, Wolff SN, Herzig GP. Lazarus HM, et al. Among authors: herzig gp. J Clin Oncol. 2008 May 10;26(14):2240-3. doi: 10.1200/JCO.2007.14.7827. J Clin Oncol. 2008. PMID: 18467711 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page